More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene
Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds
ASTRO Issues Statement On APBI For Breast Cancer
Denosumab Demonstrates Superiority Over Zometa For Bone Metastases
Lymphedema Education Helps Reduce Symptoms, Study Finds
Exercise May Help Combat Leukemia Patients’ Fatigue
Cranial Radiation Eliminated With Personalized Chemo
Young Early-Stage Patients Can Preserve Fertility
Limb-Sparing Surgery May Not Offer Better Quality of Life
AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows
Budesonide Not Beneficial For Diarrhea In Melanoma
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Michael Caputo appointed to President’s Cancer Panel
The cancer survivor and political operative says his appointment signals Trump’s interest in cancer, survivorship - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Trump targets HHS in $810M appropriations clawback
- Two years after FDA’s breast density notification rule, there is still no standard for follow-up
So far, 38 million patients have received a dense breast notification. Now what?
